Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kim

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Singapore Medical Journal|April 1, 2020
Dealing with COVID-19: initial perspectives of a small radiology departmentShawn Shi Xian Kok, Mohammad Taufik Bin Mohamed Shah, Wei Kiong Cheong, et al.
Hepatology (Baltimore, Md.)|January 26, 2008
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiationJohn W Northfield, Victoria Kasprowicz, Michaela Lucas, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-CSusanna Naggie, Kristen M Marks, Michael Hughes, et al.
Journal of Addiction Medicine|January 23, 2025
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject DrugsElenore P Bhatraju, Judith I Tsui, Moonseong Heo, et al.
Annals of Internal Medicine|September 25, 2020
Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines PanelAlice K Pau, Judith Aberg, Jason Baker, et al.
International Immunology|June 15, 2006
T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamilyMathias Lichterfeld, Katie L Williams, Stanley K Mui, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Mucosal Immunology|March 10, 2016
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16Bronwyn Gunn, Jeffrey Schneider, Maryam Shansab, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Singapore Medical Journal|April 1, 2020
Dealing with COVID-19: initial perspectives of a small radiology departmentShawn Shi Xian Kok, Mohammad Taufik Bin Mohamed Shah, Wei Kiong Cheong, et al.
Hepatology (Baltimore, Md.)|January 26, 2008
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiationJohn W Northfield, Victoria Kasprowicz, Michaela Lucas, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-CSusanna Naggie, Kristen M Marks, Michael Hughes, et al.
Journal of Addiction Medicine|January 23, 2025
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject DrugsElenore P Bhatraju, Judith I Tsui, Moonseong Heo, et al.
Annals of Internal Medicine|September 25, 2020
Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines PanelAlice K Pau, Judith Aberg, Jason Baker, et al.
International Immunology|June 15, 2006
T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamilyMathias Lichterfeld, Katie L Williams, Stanley K Mui, et al.
Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Mucosal Immunology|March 10, 2016
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16Bronwyn Gunn, Jeffrey Schneider, Maryam Shansab, et al.
Pageof 3